CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLDI CALIDI BIOTHERAPEUTICS INC

盘后交易 12-11 16:11:01 EST

1.47

-0.03

-2.00%

最高1.50	最低1.44	成交量5.50万
今开1.45	昨收1.50	日振幅3.93%
总市值1,054万	流通市值564.97万	总股本716.77万
成交额8.06万	换手率1.43%	流通股本384.33万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLDI","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC","latestPrice":1.47,"timestamp":1765486800000,"preClose":1.5,"halted":0,"volume":55035,"delay":0,"floatShares":3843300,"shares":7167700,"eps":-11.237678,"marketStatus":"盘后交易","change":-0.03,"latestTime":"12-11 16:11:01 EST","open":1.45,"high":1.5,"low":1.441,"amount":80624.084607,"amplitude":0.039333,"askPrice":1.53,"askSize":100,"bidPrice":1.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-11.237678,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":1.5,"preHourTrading":{"tag":"盘前","latestPrice":1.4991,"preClose":1.5,"latestTime":"08:37 EST","volume":57,"amount":85.3885992,"timestamp":1765460266042},"volumeRatio":0.843102},"requestUrl":"/m/hq/s/CLDI","defaultTab":"news","newsList":[{"id":"2585157950","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.21%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585157950?lang=zh_cn&edition=full","pubTime":"2025-11-21 01:39","pubTimestamp":1763660374,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日01时39分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅跳水5.21%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Psyence Biomedical Ltd.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为1030.22%、27.27%、27.11%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Seres Therapeutics, Inc.，振幅分别为53.02%、48.48%、47.15%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121013934a7073798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121013934a7073798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2584991145","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584991145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584991145?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:39","pubTimestamp":1763476745,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时39分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅下挫5.27%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1137.79%、651.95%、270.04%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为57.86%、27.99%、27.62%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223905a70227b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223905a70227b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"1164580199","title":"CALIDI BIOTHERAPEUTICS INC公布2025年第三季度财务结果及近期运营亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1164580199","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164580199?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:16","pubTimestamp":1763068573,"startTime":"0","endTime":"0","summary":"CALIDI BIOTHERAPEUTICS INC公布2025年第三季度财务结果及近期运营亮点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"gpt_icon":0},{"id":"1189671790","title":"CALIDI BIOTHERAPEUTICS INC - 出售并转让2250万股Nova Cell，交易额为600万美元 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1189671790","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189671790?lang=zh_cn&edition=full","pubTime":"2025-11-01 04:22","pubTimestamp":1761942128,"startTime":"0","endTime":"0","summary":"CALIDI BIOTHERAPEUTICS INC - 出售并转让2250万股Nova Cell，交易额为600万美元 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"gpt_icon":0},{"id":"2575050263","title":"Calidi Biotherapeutics, Inc.盘中异动 临近收盘股价大涨5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575050263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575050263?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:33","pubTimestamp":1760384011,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日03时33分，Calidi Biotherapeutics, Inc.股票出现波动，股价快速拉升5.16%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Compugen医疗、天境生物、Nanobiotix涨幅较大，Quoin Pharmaceuticals Ltd、Tvardi Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为127.68%、63.05%、41.56%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为41.90%、36.36%、34.94%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101403333194c711c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101403333194c711c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"2573299928","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573299928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573299928?lang=zh_cn&edition=full","pubTime":"2025-10-07 22:48","pubTimestamp":1759848522,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日22时48分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.77%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Spruce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Indaptus Therapeutics, Inc.、Spruce Biosciences, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为268.14%、246.99%、223.80%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Xenetic Biosciences, Inc.、Indaptus Therapeutics, Inc.，振幅分别为52.85%、45.92%、40.44%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007224842a456329e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007224842a456329e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"gpt_icon":0},{"id":"2570616958","title":"Calidi Biotherapeutics, Inc.盘中异动 下午盘大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570616958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570616958?lang=zh_cn&edition=full","pubTime":"2025-09-27 02:08","pubTimestamp":1758910093,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日02时08分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速上涨5.52%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Applied Therapeutics, Inc.、Fractyl Health, Inc.、Crinetics Pharmaceuticals, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Soligenix, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1114.44%、133.23%、102.97%，振幅较大的相关个股有Indaptus Therapeutics, Inc.、Applied Therapeutics, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为162.20%、96.89%、68.00%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092702081397ac04d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092702081397ac04d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"1192992728","title":"Calidi Biotherapeutics宣布完成690万美元承销公开发行并全额行使承销商超额配售权","url":"https://stock-news.laohu8.com/highlight/detail?id=1192992728","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192992728?lang=zh_cn&edition=full","pubTime":"2025-08-22 06:34","pubTimestamp":1755815657,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics宣布完成690万美元承销公开发行并全额行使承销商超额配售权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"gpt_icon":0},{"id":"2558866977","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速下挫5.19%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866977?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:03","pubTimestamp":1754924634,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时03分，Calidi Biotherapeutics, Inc.股票出现波动，股价快速下跌5.19%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5293.32%、437.69%、163.28%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123035494dce2fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123035494dce2fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI","AAA"],"gpt_icon":0},{"id":"2557578398","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.36%报5.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578398?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:47","pubTimestamp":1754660866,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时47分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速下跌5.36%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Bioxcel Therapeutics, Inc.、Nucana Plc涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为216.33%、98.52%、89.55%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cognition Therapeutics, Inc.，振幅分别为45.00%、29.33%、26.50%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821474694d7cfa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821474694d7cfa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2557322561","title":"Calidi Biotherapeutics, Inc.盘中异动 大幅下挫5.50%报5.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557322561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557322561?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:34","pubTimestamp":1754573678,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时34分，Calidi Biotherapeutics, Inc.股票出现波动，股价快速跳水5.50%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Palisade Bio, Inc.、Xeris制药、Niagen Bioscience, Inc.涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为638.79%、65.23%、22.83%，振幅较大的相关个股有Lantern Pharma Inc.、Palisade Bio, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为101.17%、39.00%、26.09%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213438a47b261d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213438a47b261d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2557349576","title":"Calidi Biotherapeutics, Inc.8月5日成交额为203.77万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557349576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557349576?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:38","pubTimestamp":1754444310,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Calidi Biotherapeutics, Inc.成交额为203.77万美元，成交额较昨日增加108.73%，当日成交量为31.95万股。Calidi Biotherapeutics, Inc.于2025年8月5日涨1.87%，报7.25美元，该股过去5个交易日跌4.4%，年初至今跌47.46%，过去60日涨45.58%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|203.77万|108.73%|31.95万|#|2025-08-04|97.62万|-4.84%|165.75万|#|2025-08-01|102.59万|-29.18%|183.49万|#|2025-07-31|144.85万|-52.98%|240.18万|#|2025-07-30|308.05万|-97.71%|523.62万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093832a6d576aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093832a6d576aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","BK4139","CLDI"],"gpt_icon":0},{"id":"2557392988","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下挫12.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557392988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557392988?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:33","pubTimestamp":1754400780,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时33分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅跳水12.18%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.08%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为101.48%、75.31%、62.28%，振幅较大的相关个股有Plus Therapeutics, Inc.、Hyperion Defi, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为12.18%、12.16%、10.75%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213300a476b702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213300a476b702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"2557235523","title":"Calidi Biotherapeutics, Inc.8月4日成交额为97.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557235523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557235523?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:37","pubTimestamp":1754357856,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Calidi Biotherapeutics, Inc.成交额为97.62万美元，成交额较昨日减少4.84%，当日成交量为165.75万股。Calidi Biotherapeutics, Inc.于2025年8月4日涨0.47%，报0.593美元，该股过去5个交易日涨7.84%，年初至今跌48.43%，过去60日涨37.61%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|97.62万|-4.84%|165.75万|#|2025-08-01|102.59万|-29.18%|183.49万|#|2025-07-31|144.85万|-52.98%|240.18万|#|2025-07-30|308.05万|-97.71%|523.62万|#|2025-07-29|1.35亿|5068.59%|1.79亿|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093750a6d360cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805093750a6d360cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2556387619","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387619?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314363,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速下跌5.13%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2253.90%、808.56%、390.43%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为25.64%、15.35%、13.50%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421324394cee7c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080421324394cee7c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"gpt_icon":0},{"id":"2556811113","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556811113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556811113?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:31","pubTimestamp":1754055075,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时31分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅下挫5.42%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Bioxcel Therapeutics, Inc.、天境生物、4D Molecular Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Artelo Biosciences, Inc.较为活跃，换手率分别为775.46%、110.53%、75.22%，振幅较大的相关个股有Jyong Biotech Ltd.、Fortrea Holdings Inc.、Silexion Therapeutics Corp，振幅分别为12.36%、9.76%、8.17%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213116972cfe46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213116972cfe46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","AAA","BK4139"],"gpt_icon":0},{"id":"2555836645","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.11%报0.615美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555836645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555836645?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:30","pubTimestamp":1753968638,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时30分，Calidi Biotherapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3598.67%、1700.67%、1664.32%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.、Moolec Science Sa，振幅分别为32.00%、13.59%、7.86%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213038972a4b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213038972a4b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"2555093550","title":"Calidi Biotherapeutics, Inc.7月29日成交额为1.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555093550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555093550?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:39","pubTimestamp":1753839566,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Calidi Biotherapeutics, Inc.成交额为1.35亿美元，成交额较昨日增加5068.59%，当日成交量为1.79亿股。Calidi Biotherapeutics, Inc.于2025年7月29日涨14.94%，报0.632美元，该股过去5个交易日跌9.24%，年初至今跌45.07%，过去60日涨30.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|1.35亿|5068.59%|1.79亿|#|2025-07-28|260.55万|32.89%|462.37万|#|2025-07-25|196.07万|5.96%|275.49万|#|2025-07-24|185.03万|14.85%|235.97万|#|2025-07-23|161.10万|16.47%|217.53万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093931a46a857e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093931a46a857e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139","AAA"],"gpt_icon":0},{"id":"2554721697","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌10.99%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721697?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:31","pubTimestamp":1753709492,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时31分，Calidi Biotherapeutics, Inc.股票出现波动，股价快速下挫10.99%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为222.14%、80.97%、80.33%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.，振幅分别为35.83%、23.86%、10.21%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213132a467d969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213132a467d969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAA","CLDI","BK4139"],"gpt_icon":0},{"id":"2553922224","title":"Calidi Biotherapeutics, Inc.7月23日成交额为161.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553922224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553922224?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:35","pubTimestamp":1753320956,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Calidi Biotherapeutics, Inc.成交额为161.10万美元，成交额较昨日增加16.47%，当日成交量为217.53万股。Calidi Biotherapeutics, Inc.于2025年7月23日涨6.21%，报0.739美元，该股过去5个交易日涨16.96%，年初至今跌35.72%，过去60日涨53.04%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|161.10万|16.47%|217.53万|#|2025-07-22|138.32万|-67.56%|202.08万|#|2025-07-21|426.38万|170.32%|602.68万|#|2025-07-18|157.73万|-25.55%|256.52万|#|2025-07-17|211.85万|-27.40%|353.94万|Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，技术主要在武装免疫系统以对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093750a4601cae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724093750a4601cae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAA","CLDI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calidibio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0791},{"period":"3month","weight":-0.0798},{"period":"6month","weight":-0.6377},{"period":"1year","weight":-0.9342},{"period":"ytd","weight":-0.8913}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Calidi Biotherapeutics, Inc.成立时是特拉华州的一家临床阶段免疫肿瘤公司，该公司是一家临床阶段的免疫肿瘤学公司，正在开发基于同种异体干细胞的专有平台，以增强和递送溶瘤病毒以及可能的分子给癌症患者。该公司目前正在开发两个基于干细胞的专有平台和一个包膜牛痘病毒平台，旨在保护溶瘤病毒，无论是天然的还是工程的，不被患者的免疫防御所中和，从而允许肿瘤细胞受到更大的感染，并导致溶瘤病毒的抗肿瘤活性比传统的“裸”溶瘤病毒疗法有潜在的改善。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.200247},{"month":2,"riseRate":0.75,"avgChangeRate":-0.022689},{"month":3,"riseRate":0.5,"avgChangeRate":-0.101198},{"month":4,"riseRate":0.25,"avgChangeRate":-0.200168},{"month":5,"riseRate":0.25,"avgChangeRate":-0.071752},{"month":6,"riseRate":0.75,"avgChangeRate":-0.069766},{"month":7,"riseRate":0.75,"avgChangeRate":0.345315},{"month":8,"riseRate":0.25,"avgChangeRate":-0.291823},{"month":9,"riseRate":0,"avgChangeRate":-0.182897},{"month":10,"riseRate":0.75,"avgChangeRate":-0.07151},{"month":11,"riseRate":0.5,"avgChangeRate":0.188661},{"month":12,"riseRate":0.2,"avgChangeRate":-0.147642}],"exchange":"AMEX","name":"CALIDI BIOTHERAPEUTICS INC","nameEN":"CALIDI BIOTHERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALIDI BIOTHERAPEUTICS INC,CLDI,CALIDI BIOTHERAPEUTICS INC股票,CALIDI BIOTHERAPEUTICS INC股票老虎,CALIDI BIOTHERAPEUTICS INC股票老虎国际,CALIDI BIOTHERAPEUTICS INC行情,CALIDI BIOTHERAPEUTICS INC股票行情,CALIDI BIOTHERAPEUTICS INC股价,CALIDI BIOTHERAPEUTICS INC股市,CALIDI BIOTHERAPEUTICS INC股票价格,CALIDI BIOTHERAPEUTICS INC股票交易,CALIDI BIOTHERAPEUTICS INC股票购买,CALIDI BIOTHERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况